| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 1/20-1/50 | Human,Mouse,Rat |
| IHC | IHC:1/100-1/200;IHF:1/50-1/200 | Human,Mouse,Rat |
| ICC | 1/50-1/200 | Human,Mouse,Rat |
| FCM | 1/20-1/100 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | C-C chemokine receptor type 2; C-C CKR-2; CC chemokine receptor type 2; CC CKR 2; CC-CKR-2; CCCKR2; CCR 2; CCR-2;; CCR1L;; CCR2;;CCR2 |
| WB Predicted band size | 42 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | A synthesized peptide derived from human CCR2 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol. |
+ +
以下是关于CCR2/CKR2抗体的3篇示例文献(注：文献为虚构示例，仅供格式参考)：
---
1. **文献名称**：*Selective Inhibition of CCR2 Signaling by a Novel Monoclonal Antibody Suppresses Neuroinflammation in Experimental Autoimmune Encephalomyelitis*
**作者**：Zhang Y, et al.
**摘要**：本研究开发了一种针对CCR2受体胞外域的单克隆抗体，可特异性阻断CCL2介导的信号通路。在实验性自身免疫性脑脊髓炎(EAE)模型中，该抗体显著抑制小胶质细胞活化和中枢神经系统炎症，提示其在多发性硬化症中的治疗潜力。
---
2. **文献名称**：*Anti-CCR2 Antibody-Conjugated Nanoparticles for Targeted Delivery in Atherosclerotic Plaque Imaging*
**作者**：Wang L, et al.
**摘要**：作者将抗CCR2抗体与近红外荧光纳米颗粒结合，用于动脉粥样硬化斑块中单核/巨噬细胞的特异性标记。体内实验表明，该探针能精准定位斑块区域，为无创影像诊断提供了新策略。
---
3. **文献名称**：*A Neutralizing CCR2 Antibody Reverses Chemotherapy Resistance by Reprogramming the Tumor Microenvironment*
**作者**：Garcia-Rojas M, et al.
**摘要**：研究发现，中和性CCR2抗体可通过阻断肿瘤相关巨噬细胞(TAMs)的招募，重塑免疫抑制性肿瘤微环境，增强化疗药物在胰腺癌模型中的疗效，并减少转移灶形成。
---
**建议**：如需真实文献，可访问PubMed或Google Scholar，搜索关键词如“CCR2 antibody therapeutic”、“anti-CCR2 neutralization”或结合具体疾病(如癌症、动脉粥样硬化)。近年研究多聚焦于抗体药物偶联物(ADC)或联合免疫疗法。
×
